Group One Trading’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,509
| Closed | -$465K | – | 9042 |
|
|
2021
Q4 | $542K | Sell |
1,509
-300
| -17% | -$101K | ﹤0.01% | 4042 |
|
|
2021
Q3 | $589K | Sell |
1,809
-144
| -7% | -$48.8K | ﹤0.01% | 4005 |
|
|
2021
Q2 | $610K | Buy |
1,953
+1,063
| +119% | +$326K | ﹤0.01% | 3996 |
|
|
2021
Q1 | $284K | Sell |
890
-18
| -2% | -$5.76K | ﹤0.01% | 4643 |
|
|
2020
Q4 | $294K | Sell |
908
-1,400
| -61% | -$387K | ﹤0.01% | 3758 |
|
|
2020
Q3 | $639K | Buy |
+2,308
| New | +$665K | ﹤0.01% | 2628 |
|
|
2020
Q1 | – | Sell |
-15,992
| Closed | -$2.65M | – | 5933 |
|
|
2019
Q4 | $2.73M | Sell |
15,992
-245
| -2% | -$45.4K | 0.02% | 1049 |
|
|
2019
Q3 | $2.89M | Buy |
16,237
+1,748
| +12% | +$378K | 0.02% | 928 |
|
|
2019
Q2 | $3.77M | Buy |
14,489
+11,241
| +346% | +$2.98M | 0.03% | 684 |
|
|
2019
Q1 | $928K | Sell |
3,248
-375
| -10% | -$125K | 0.01% | 1460 |
|
|
2018
Q4 | $1.18M | Sell |
3,623
-2,337
| -39% | -$812K | 0.01% | 1387 |
|
|
2018
Q3 | $2.68M | Buy |
5,960
+3,343
| +128% | +$1.32M | 0.02% | 945 |
|
|
2018
Q2 | $1.07M | Buy |
2,617
+2,157
| +469% | +$781K | 0.01% | 1664 |
|
|
2018
Q1 | $134K | Sell |
460
-2,332
| -84% | -$591K | ﹤0.01% | 3070 |
|
|
2017
Q4 | $523K | Buy |
2,792
+2,690
| +2,637% | +$502K | ﹤0.01% | 2217 |
|
|
2017
Q3 | $17K | Buy |
102
+41
| +67% | +$6.2K | ﹤0.01% | 4136 |
|
|
2017
Q2 | $9K | Sell |
61
-803
| -93% | -$108K | ﹤0.01% | 4254 |
|
|
2017
Q1 | $108K | Buy |
864
+600
| +227% | +$69.5K | ﹤0.01% | 2925 |
|
|
2016
Q4 | $30K | Sell |
264
-4,200
| -94% | -$487K | ﹤0.01% | 3534 |
|
|
2016
Q3 | $574K | Buy |
+4,464
| New | +$535K | 0.01% | 1716 |
|
|
2016
Q2 | – | Sell |
-528
| Closed | -$50K | – | 5041 |
|
|
2016
Q1 | $50K | Sell |
528
-5,763
| -92% | -$486K | ﹤0.01% | 3254 |
|
|
2015
Q4 | $568K | Buy |
+6,291
| New | +$534K | 0.01% | 1721 |
|
|
2015
Q3 | – | Sell |
-455
| Closed | -$30K | – | 5316 |
|
|
2015
Q2 | $30K | Buy |
+455
| New | +$30.2K | ﹤0.01% | 3840 |
|
|
2015
Q1 | – | Sell |
-13,082
| Closed | -$498K | – | 5332 |
|
|
2014
Q4 | $498K | Buy |
13,082
+12,700
| +3,325% | +$401K | 0.01% | 1562 |
|
|
2014
Q3 | $9K | Buy |
+382
| New | +$9.68K | ﹤0.01% | 4525 |
|
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Group One Trading's ABMD Position: Q1 2022 in Review
Group One Trading sold out of Abiomed Inc (ABMD) in Q1 2022, closing a stake of 1,509 shares — an estimated $465K sold.
Group One Trading first reported a position in ABMD in Q3 2014 and held it in 25 quarters. The position peaked at $3.77M in Q2 2019. 500 funds tracked by Wall St. Rank hold ABMD as of Q1 2022.
- Group One Trading reported no remaining Abiomed Inc position as of Q1 2022 after selling out during the quarter.
- Group One Trading sold 1,509 Abiomed Inc shares in Q1 2022, an estimated $465K.
- Group One Trading first reported a position in Abiomed Inc in Q3 2014 and held it in 25 quarters.
- Group One Trading's Abiomed Inc position peaked at $3.77M in Q2 2019.
- 500 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2022.
Based on Group One Trading's 13F filing for Q1 2022, filed 12 May 2022.